TY - JOUR AU - Baylin, S. B. AU - Jones, P. A. PY - 2011 DA - 2011// TI - A decade of exploring the cancer epigenome - biological and translational implications JO - Nat Rev Cancer VL - 11 UR - https://doi.org/10.1038/nrc3130 DO - 10.1038/nrc3130 ID - Baylin2011 ER - TY - JOUR AU - Esteller, M. PY - 2007 DA - 2007// TI - Cancer epigenomics: DNA methylomes and histone-modification maps JO - Nat Rev Genet VL - 8 UR - https://doi.org/10.1038/nrg2005 DO - 10.1038/nrg2005 ID - Esteller2007 ER - TY - JOUR AU - Quintas-Cardama, A. AU - Santos, F. P. AU - Garcia-Manero, G. PY - 2010 DA - 2010// TI - Therapy with azanucleosides for myelodysplastic syndromes JO - Nat Rev Clin Oncol VL - 7 UR - https://doi.org/10.1038/nrclinonc.2010.87 DO - 10.1038/nrclinonc.2010.87 ID - Quintas-Cardama2010 ER - TY - JOUR AU - Wouters, B. J. AU - Delwel, R. PY - 2016 DA - 2016// TI - Epigenetics and approaches to targeted epigenetic therapy in acute myeloid leukemia JO - Blood. VL - 127 UR - https://doi.org/10.1182/blood-2015-07-604512 DO - 10.1182/blood-2015-07-604512 ID - Wouters2016 ER - TY - JOUR AU - Pechalrieu, D. AU - Etievant, C. AU - Arimondo, P. B. PY - 2017 DA - 2017// TI - DNA methyltransferase inhibitors in cancer: from pharmacology to translational studies JO - Biochem Pharmacol VL - 129 UR - https://doi.org/10.1016/j.bcp.2016.12.004 DO - 10.1016/j.bcp.2016.12.004 ID - Pechalrieu2017 ER - TY - JOUR AU - Linnekamp, J. F. AU - Butter, R. AU - Spijker, R. AU - Medema, J. P. AU - Laarhoven, H. W. M. PY - 2017 DA - 2017// TI - Clinical and biological effects of demethylating agents on solid tumours - a systematic review JO - Cancer Treat Rev VL - 54 UR - https://doi.org/10.1016/j.ctrv.2017.01.004 DO - 10.1016/j.ctrv.2017.01.004 ID - Linnekamp2017 ER - TY - JOUR AU - Nervi, C. AU - Marinis, E. AU - Codacci-Pisanelli, G. PY - 2015 DA - 2015// TI - Epigenetic treatment of solid tumours: a review of clinical trials JO - Clin Epigenetics VL - 7 UR - https://doi.org/10.1186/s13148-015-0157-2 DO - 10.1186/s13148-015-0157-2 ID - Nervi2015 ER - TY - JOUR AU - Juergens, R. A. AU - Wrangle, J. AU - Vendetti, F. P. AU - Murphy, S. C. AU - Zhao, M. AU - Coleman, B. PY - 2011 DA - 2011// TI - Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer JO - Cancer Discov VL - 1 UR - https://doi.org/10.1158/2159-8290.CD-11-0214 DO - 10.1158/2159-8290.CD-11-0214 ID - Juergens2011 ER - TY - JOUR AU - Matei, D. AU - Fang, F. AU - Shen, C. AU - Schilder, J. AU - Arnold, A. AU - Zeng, Y. PY - 2012 DA - 2012// TI - Epigenetic resensitization to platinum in ovarian cancer JO - Cancer Res VL - 72 UR - https://doi.org/10.1158/0008-5472.CAN-11-3909 DO - 10.1158/0008-5472.CAN-11-3909 ID - Matei2012 ER - TY - JOUR AU - Mei, Q. AU - Chen, M. AU - Lu, X. AU - Li, X. AU - Duan, F. AU - Wang, M. PY - 2015 DA - 2015// TI - An open-label, single-arm, phase I/II study of lower-dose decitabine based therapy in patients with advanced hepatocellular carcinoma JO - Oncotarget. VL - 6 UR - https://doi.org/10.18632/oncotarget.3677 DO - 10.18632/oncotarget.3677 ID - Mei2015 ER - TY - JOUR AU - Chen, M. AU - Nie, J. AU - Liu, Y. AU - Li, X. AU - Zhang, Y. AU - Brock, M. V. PY - 2018 DA - 2018// TI - Phase Ib/II study of safety and efficacy of low-dose decitabine-primed chemoimmunotherapy in patients with drug-resistant relapsed/refractory alimentary tract cancer JO - Int J Cancer VL - 143 UR - https://doi.org/10.1002/ijc.31531 DO - 10.1002/ijc.31531 ID - Chen2018 ER - TY - JOUR AU - Momparler, R. L. PY - 2005 DA - 2005// TI - Epigenetic therapy of cancer with 5-aza-2′-deoxycytidine (decitabine) JO - Semin Oncol VL - 32 UR - https://doi.org/10.1053/j.seminoncol.2005.07.008 DO - 10.1053/j.seminoncol.2005.07.008 ID - Momparler2005 ER - TY - JOUR AU - Issa, J. P. AU - Garcia-Manero, G. AU - Giles, F. J. AU - Mannari, R. AU - Thomas, D. AU - Faderl, S. PY - 2004 DA - 2004// TI - Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies JO - Blood. VL - 103 UR - https://doi.org/10.1182/blood-2003-03-0687 DO - 10.1182/blood-2003-03-0687 ID - Issa2004 ER - TY - JOUR AU - Issa, J. P. AU - Gharibyan, V. AU - Cortes, J. AU - Jelinek, J. AU - Morris, G. AU - Verstovsek, S. PY - 2005 DA - 2005// TI - Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.11.981 DO - 10.1200/JCO.2005.11.981 ID - Issa2005 ER - TY - JOUR AU - Kantarjian, H. AU - Oki, Y. AU - Garcia-Manero, G. AU - Huang, X. AU - O'Brien, S. AU - Cortes, J. PY - 2007 DA - 2007// TI - Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia JO - Blood. VL - 109 UR - https://doi.org/10.1182/blood-2006-05-021162 DO - 10.1182/blood-2006-05-021162 ID - Kantarjian2007 ER - TY - JOUR AU - Bender, C. M. AU - Pao, M. M. AU - Jones, P. A. PY - 1998 DA - 1998// TI - Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines JO - Cancer Res VL - 58 ID - Bender1998 ER - TY - JOUR AU - Tsai, H. C. AU - Li, H. AU - Neste, L. AU - Cai, Y. AU - Robert, C. AU - Rassool, F. V. PY - 2012 DA - 2012// TI - Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells JO - Cancer Cell VL - 21 UR - https://doi.org/10.1016/j.ccr.2011.12.029 DO - 10.1016/j.ccr.2011.12.029 ID - Tsai2012 ER - TY - JOUR AU - Chiappinelli, K. B. AU - Strissel, P. L. AU - Desrichard, A. AU - Li, H. AU - Henke, C. AU - Akman, B. PY - 2015 DA - 2015// TI - Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses JO - Cell. VL - 162 UR - https://doi.org/10.1016/j.cell.2015.07.011 DO - 10.1016/j.cell.2015.07.011 ID - Chiappinelli2015 ER - TY - JOUR AU - Roulois, D. AU - Loo Yau, H. AU - Singhania, R. AU - Wang, Y. AU - Danesh, A. AU - Shen, S. Y. PY - 2015 DA - 2015// TI - DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts JO - Cell. VL - 162 UR - https://doi.org/10.1016/j.cell.2015.07.056 DO - 10.1016/j.cell.2015.07.056 ID - Roulois2015 ER - TY - JOUR AU - Maeda, M. AU - Takeshima, H. AU - Iida, N. AU - Hattori, N. AU - Yamashita, S. AU - Moro, H. PY - 2020 DA - 2020// TI - Cancer cell niche factors secreted from cancer-associated fibroblast by loss of H3K27me3 JO - Gut. VL - 69 UR - https://doi.org/10.1136/gutjnl-2018-317645 DO - 10.1136/gutjnl-2018-317645 ID - Maeda2020 ER - TY - JOUR AU - Pidsley, R. AU - Lawrence, M. G. AU - Zotenko, E. AU - Niranjan, B. AU - Statham, A. AU - Song, J. PY - 2018 DA - 2018// TI - Enduring epigenetic landmarks define the cancer microenvironment JO - Genome Res VL - 28 UR - https://doi.org/10.1101/gr.229070.117 DO - 10.1101/gr.229070.117 ID - Pidsley2018 ER - TY - JOUR AU - Lu, Z. AU - Zou, J. AU - Li, S. AU - Topper, M. J. AU - Tao, Y. AU - Zhang, H. PY - 2020 DA - 2020// TI - Epigenetic therapy inhibits metastases by disrupting premetastatic niches JO - Nature. VL - 579 UR - https://doi.org/10.1038/s41586-020-2054-x DO - 10.1038/s41586-020-2054-x ID - Lu2020 ER - TY - JOUR AU - Brandes, J. C. AU - Engeland, M. AU - Wouters, K. A. AU - Weijenberg, M. P. AU - Herman, J. G. PY - 2005 DA - 2005// TI - CHFR promoter hypermethylation in colon cancer correlates with the microsatellite instability phenotype JO - Carcinogenesis. VL - 26 UR - https://doi.org/10.1093/carcin/bgi058 DO - 10.1093/carcin/bgi058 ID - Brandes2005 ER - TY - JOUR AU - Kong, X. AU - Chen, J. AU - Xie, W. AU - Brown, S. M. AU - Cai, Y. AU - Wu, K. PY - 2019 DA - 2019// TI - Defining UHRF1 domains that support maintenance of human colon cancer DNA methylation and oncogenic properties JO - Cancer Cell VL - 35 UR - https://doi.org/10.1016/j.ccell.2019.03.003 DO - 10.1016/j.ccell.2019.03.003 ID - Kong2019 ER - TY - JOUR AU - Suzuki, H. AU - Gabrielson, E. AU - Chen, W. AU - Anbazhagan, R. AU - Engeland, M. AU - Weijenberg, M. P. PY - 2002 DA - 2002// TI - A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer JO - Nat Genet VL - 31 UR - https://doi.org/10.1038/ng892 DO - 10.1038/ng892 ID - Suzuki2002 ER - TY - JOUR AU - Alcorta, D. A. AU - Xiong, Y. AU - Phelps, D. AU - Hannon, G. AU - Beach, D. AU - Barrett, J. C. PY - 1996 DA - 1996// TI - Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts JO - Proc Natl Acad Sci U S A VL - 93 UR - https://doi.org/10.1073/pnas.93.24.13742 DO - 10.1073/pnas.93.24.13742 ID - Alcorta1996 ER - TY - JOUR AU - Hara, E. AU - Smith, R. AU - Parry, D. AU - Tahara, H. AU - Stone, S. AU - Peters, G. PY - 1996 DA - 1996// TI - Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence JO - Mol Cell Biol VL - 16 UR - https://doi.org/10.1128/MCB.16.3.859 DO - 10.1128/MCB.16.3.859 ID - Hara1996 ER - TY - JOUR AU - Schneider, B. J. AU - Shah, M. A. AU - Klute, K. AU - Ocean, A. AU - Popa, E. AU - Altorki, N. PY - 2017 DA - 2017// TI - Phase I study of epigenetic priming with azacitidine prior to standard neoadjuvant chemotherapy for patients with resectable gastric and esophageal adenocarcinoma: evidence of tumor hypomethylation as an indicator of major histopathologic response JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-1896 DO - 10.1158/1078-0432.CCR-16-1896 ID - Schneider2017 ER - TY - JOUR AU - Singal, R. AU - Ramachandran, K. AU - Gordian, E. AU - Quintero, C. AU - Zhao, W. AU - Reis, I. M. PY - 2015 DA - 2015// TI - Phase I/II study of azacitidine, docetaxel, and prednisone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel-based therapy JO - Clin Genitourin Cancer VL - 13 UR - https://doi.org/10.1016/j.clgc.2014.07.008 DO - 10.1016/j.clgc.2014.07.008 ID - Singal2015 ER - TY - JOUR AU - Tawbi, H. A. AU - Beumer, J. H. AU - Tarhini, A. A. AU - Moschos, S. AU - Buch, S. C. AU - Egorin, M. J. PY - 2013 DA - 2013// TI - Safety and efficacy of decitabine in combination with temozolomide in metastatic melanoma: a phase I/II study and pharmacokinetic analysis JO - Ann Oncol VL - 24 UR - https://doi.org/10.1093/annonc/mds591 DO - 10.1093/annonc/mds591 ID - Tawbi2013 ER - TY - JOUR AU - Bauman, J. AU - Verschraegen, C. AU - Belinsky, S. AU - Muller, C. AU - Rutledge, T. AU - Fekrazad, M. PY - 2012 DA - 2012// TI - A phase I study of 5-azacytidine and erlotinib in advanced solid tumor malignancies JO - Cancer Chemother Pharmacol VL - 69 UR - https://doi.org/10.1007/s00280-011-1729-2 DO - 10.1007/s00280-011-1729-2 ID - Bauman2012 ER - TY - JOUR AU - Garrido-Laguna, I. AU - McGregor, K. A. AU - Wade, M. AU - Weis, J. AU - Gilcrease, W. AU - Burr, L. PY - 2013 DA - 2013// TI - A phase I/II study of decitabine in combination with panitumumab in patients with wild-type (wt) KRAS metastatic colorectal cancer JO - Investig New Drugs VL - 31 UR - https://doi.org/10.1007/s10637-013-9947-6 DO - 10.1007/s10637-013-9947-6 ID - Garrido-Laguna2013 ER - TY - STD TI - Becht E, McInnes L, Healy J, Dutertre CA, Kwok IWH, Ng LG, et al. Dimensionality reduction for visualizing single-cell data using UMAP. Nat Biotechnol. 2018. ID - ref33 ER - TY - JOUR AU - Takeshima, H. AU - Niwa, T. AU - Takahashi, T. AU - Wakabayashi, M. AU - Yamashita, S. AU - Ando, T. PY - 2015 DA - 2015// TI - Frequent involvement of chromatin remodeler alterations in gastric field cancerization JO - Cancer Lett VL - 357 UR - https://doi.org/10.1016/j.canlet.2014.11.038 DO - 10.1016/j.canlet.2014.11.038 ID - Takeshima2015 ER - TY - JOUR AU - Iida, N. AU - Okuda, Y. AU - Ogasawara, O. AU - Yamashita, S. AU - Takeshima, H. AU - Ushijima, T. PY - 2018 DA - 2018// TI - MACON: a web tool for computing DNA methylation data obtained by the Illumina Infinium Human DNA methylation BeadArray JO - Epigenomics. VL - 10 UR - https://doi.org/10.2217/epi-2017-0093 DO - 10.2217/epi-2017-0093 ID - Iida2018 ER - TY - JOUR AU - Yoda, Y. AU - Takeshima, H. AU - Niwa, T. AU - Kim, J. G. AU - Ando, T. AU - Kushima, R. PY - 2015 DA - 2015// TI - Integrated analysis of cancer-related pathways affected by genetic and epigenetic alterations in gastric cancer JO - Gastric Cancer VL - 18 UR - https://doi.org/10.1007/s10120-014-0348-0 DO - 10.1007/s10120-014-0348-0 ID - Yoda2015 ER -